The role of the interleukin-1 - Receptor antagonist in blocking inflammation mediated by interleukin-1

New England Journal of Medicine

Volumn 343, Issue 10, 2000, Pages 732-734

  Dinarello, C A ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT;

ARTERITIS; ARTICLE; AUTOIMMUNE DISEASE; BONE EROSION; INFLAMMATION; INFLAMMATORY DISEASE; KNOCKOUT MOUSE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; TISSUE REGENERATION;

ANIMALS; ARTERITIS; ARTHRITIS, RHEUMATOID; HUMANS; INFLAMMATION; INTERLEUKIN-1; MICE; RECEPTORS, INTERLEUKIN-1;

EID: 0034618862     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM200009073431011     Document Type: Article

References (5)

1. Development of chronic inflammatory arthropathy resembling rheumatoid arthritis in interleukin 1 receptor antagonist-deficient mice
2. Arterial inflammation in mice lacking the interleukin 1 receptor antagonist gene
3. Biological basis for interleukin-1 in disease
4. Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist
5. Treatment of interleukin-1 receptor antagonist in combination with methotrexate (MTX) in rheumatoid arthritis (RA) patients